Biricodar Dicitrate

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameBiricodar Dicitrate
Drug Alias Namebiricodarum比立克达枸橼酸比立考达枸橼酸比立考达Incel +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-glycoprotein 1 inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A